325 related articles for article (PubMed ID: 26611474)
21. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
[TBL] [Abstract][Full Text] [Related]
22. An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia.
Geron I; Savino AM; Fishman H; Tal N; Brown J; Turati VA; James C; Sarno J; Hameiri-Grossman M; Lee YN; Rein A; Maniriho H; Birger Y; Zemlyansky A; Muler I; Davis KL; Marcu-Malina V; Mattson N; Parnas O; Wagener R; Fischer U; Barata JT; Jamieson CHM; Müschen M; Chen CW; Borkhardt A; Kirsch IR; Nagler A; Enver T; Izraeli S
Nat Commun; 2022 Feb; 13(1):659. PubMed ID: 35115489
[TBL] [Abstract][Full Text] [Related]
23. Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development.
Carpino N; Thierfelder WE; Chang MS; Saris C; Turner SJ; Ziegler SF; Ihle JN
Mol Cell Biol; 2004 Mar; 24(6):2584-92. PubMed ID: 14993294
[TBL] [Abstract][Full Text] [Related]
24. TSLP or IL-7 provide an IL-7Rα signal that is critical for human B lymphopoiesis.
Milford TA; Su RJ; Francis OL; Baez I; Martinez SR; Coats JS; Weldon AJ; Calderon MN; Nwosu MC; Botimer AR; Suterwala BT; Zhang XB; Morris CL; Weldon DJ; Dovat S; Payne KJ
Eur J Immunol; 2016 Sep; 46(9):2155-61. PubMed ID: 27325567
[TBL] [Abstract][Full Text] [Related]
25. STAT5 in B cell development and leukemia.
Malin S; McManus S; Busslinger M
Curr Opin Immunol; 2010 Apr; 22(2):168-76. PubMed ID: 20227268
[TBL] [Abstract][Full Text] [Related]
26. Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation.
Scheeren FA; van Lent AU; Nagasawa M; Weijer K; Spits H; Legrand N; Blom B
Eur J Immunol; 2010 Apr; 40(4):955-65. PubMed ID: 20127673
[TBL] [Abstract][Full Text] [Related]
27. PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development.
Yu M; Chen Y; Zeng H; Zheng Y; Fu G; Zhu W; Broeckel U; Aggarwal P; Turner A; Neale G; Guy C; Zhu N; Chi H; Wen R; Wang D
Nat Commun; 2017 Nov; 8(1):1457. PubMed ID: 29133930
[TBL] [Abstract][Full Text] [Related]
28. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
[TBL] [Abstract][Full Text] [Related]
29. Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line.
Coats JS; Baez I; Stoian C; Milford TM; Zhang X; Francis OL; Su R; Payne KJ
J Vis Exp; 2017 May; (123):. PubMed ID: 28518123
[TBL] [Abstract][Full Text] [Related]
30. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
Yoda A; Yoda Y; Chiaretti S; Bar-Natan M; Mani K; Rodig SJ; West N; Xiao Y; Brown JR; Mitsiades C; Sattler M; Kutok JL; DeAngelo DJ; Wadleigh M; Piciocchi A; Dal Cin P; Bradner JE; Griffin JD; Anderson KC; Stone RM; Ritz J; Foà R; Aster JC; Frank DA; Weinstock DM
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):252-7. PubMed ID: 20018760
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function.
Wohlmann A; Sebastian K; Borowski A; Krause S; Friedrich K
Biol Chem; 2010; 391(2-3):181-186. PubMed ID: 20128689
[TBL] [Abstract][Full Text] [Related]
32. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
[TBL] [Abstract][Full Text] [Related]
33. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience.
Konoplev S; Lu X; Konopleva M; Jain N; Ouyang J; Goswami M; Roberts KG; Valentine M; Mullighan CG; Bueso-Ramos C; Zweidler-McKay PA; Jorgensen JL; Wang SA
Am J Clin Pathol; 2017 Apr; 147(4):357-363. PubMed ID: 28340183
[TBL] [Abstract][Full Text] [Related]
34. TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice.
Tsuzuki S; Seto M
Stem Cells; 2013 Feb; 31(2):236-47. PubMed ID: 23135987
[TBL] [Abstract][Full Text] [Related]
35. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.
Rochman Y; Kashyap M; Robinson GW; Sakamoto K; Gomez-Rodriguez J; Wagner KU; Leonard WJ
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19455-60. PubMed ID: 20974963
[TBL] [Abstract][Full Text] [Related]
36. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
Schwartzman O; Savino AM; Gombert M; Palmi C; Cario G; Schrappe M; Eckert C; von Stackelberg A; Huang JY; Hameiri-Grossman M; Avigad S; Te Kronnie G; Geron I; Birger Y; Rein A; Zarfati G; Fischer U; Mukamel Z; Stanulla M; Biondi A; Cazzaniga G; Vetere A; Wagner BK; Chen Z; Chen SJ; Tanay A; Borkhardt A; Izraeli S
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4030-E4039. PubMed ID: 28461505
[TBL] [Abstract][Full Text] [Related]
37. Correlation of the surface expression of thymic stromal lymphopoietin receptor with the presence of CRLF2 gene rearrangements in children with B-lineage acute lymphoblastic leukemia.
Demina I; Zerkalenkova E; Soldatkina O; Kazakova A; Semchenkova A; Goncharova M; Novichkova G; Maschan M; Karachunskiy A; Olshanskaya Y; Popov A
Int J Lab Hematol; 2023 Jun; 45(3):337-343. PubMed ID: 36748719
[TBL] [Abstract][Full Text] [Related]
38. PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: new options for targeted therapy.
Martelli AM; Tabellini G; Ricci F; Evangelisti C; Chiarini F; Bortul R; McCubrey JA; Manzoli FA
Adv Biol Regul; 2012 Jan; 52(1):214-27. PubMed ID: 21983557
[No Abstract] [Full Text] [Related]
39. Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway.
Liu D; Huang Y; Zeng J; Chen B; Huang N; Guo N; Liu L; Xu H; Mo X; Li W
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1629-40. PubMed ID: 21861134
[TBL] [Abstract][Full Text] [Related]
40. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors.
Batista A; Barata JT; Raderschall E; Sallan SE; Carlesso N; Nadler LM; Cardoso AA
Exp Hematol; 2011 Apr; 39(4):457-472.e3. PubMed ID: 21277936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
